Searched for
SENORES PHARMACEUTICALS
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...- Stock Radar: Investors book profits in Senores Pharma after hitting record high in July 2025; should you buy the dip?Senores Pharmaceuticals, part of the BSE Smallcap index, is showing bullish signals after a Cup pattern breakout in July 2025. Experts sugg...
- Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from WockhardtSenores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migrai...
- Senores Pharma to acquire 14 ANDAs from Dr Reddy's LaboratoriesSenores Pharmaceuticals of Gujarat has signed an agreement to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories. Th...
- Stock market update: Stocks that hit 52-week highs on NSE in today's tradeVimta Labs, Senores Pharmaceutic, Pansari Developers, Supreme Holdings and KRN Heat Exchanger, hit their fresh 52-week highs during the day.
- Kothari Products announces 1:1 bonus share issue, stock up 7%Kothari Products announced a 1:1 bonus share issue, causing a 7.4% stock rise to Rs 209.70. The issuance will be financed from free reserve...
- Utkarsh Small Finance Bank shares jump 4% after approving sale of NPAs worth Rs 355 croreUtkarsh Small Finance Bank plans to sell its non-performing assets and written-off loans to an asset reconstruction company. The loans amou...
- IL&FS Engineering shares jump 5% after securing Rs 303 crore Bhubaneswar Metro projectIL&FS Engineering and Construction has been awarded a Rs 302.82 crore project from Ceigall India for the Bhubaneswar Metro Phase-I. The pro...
- Senores Pharma shares list at 53% premium over IPO priceSenores Pharmaceuticals’ shares debuted with over a 50% premium on Indian exchanges, reflecting a robust investor response to the IPO, whic...
- Senores Pharmaceuticals IPO: Check allotment status, GMP, listing date and other detailsSenores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's we...
- Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key detailsSenores Pharma's IPO subscription was oversubscribed at 93.41 times driven by retail, non-institutional, and qualified institutional buyers...
- Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price bandRetail investors subscribed to the issue 38.34 times, while non-institutional investors (NIIs) subscribed 24.48 times. Qualified institutio...
- Senores Pharma IPO subscribed 1.8 times on Day 1: Check key dates, price band, GMP and reviewSenores Pharmaceuticals' IPO received 1.8 times subscription on its opening day, driven primarily by retail investors, who oversubscribed b...
- Senores Pharma has niche positives, can be a long-term betIncorporated in 2017, the company identifies, develops and commercialises speciality and complex niche products in mid-market range. It als...
- Senores Pharmaceuticals collects Rs 261 cr from anchor investorsSenores Pharmaceuticals Ltd on Thursday said it has secured nearly Rs 261 crore from anchor investors, ahead of its initial share-sale open...
- Senores Pharmaceuticals sets price band at Rs 372-391 for Rs 582 crore IPO. Check detailsAhmedabad-based Senores Pharmaceuticals is set to launch its IPO on December 20, with a price band of Rs 372-391. The issue includes a fres...
- Senores Pharmaceuticals IPO to open for bidding on December 20. Check detailsSenores Pharmaceuticals is launching its IPO on December 20. The issue comprises a fresh issue of Rs 500 crore and an OFS of 21 lakh shares...
- Sebi green lights issues of Sagility, Senores PharmaWhen a company receives a final observation from Sebi, it’s a signal from the regulator to go ahead with the IPO process.
- Senores Pharmaceuticals files DRHP for IPO. Check detailsUnder the OFS, up to 8.5 lakh equity shares by Swapnil Jatinbhai Shah, up to 5.5 lakh equity shares by Ashokkumar Vijaysinh Barot, up to 3 ...
- Aurobindo Pharma to divest Chinese armHyderabad-based Aurobindo Pharma has decided to disinvest its loss-making subsidiary in China while acquiring a small manufacturing unit in...
Load More
